The effect of Tylenol on autism risk due to maternal illness during pregnancy [Registered Report Stage 1 Protocol]

ABSTRACTBackground: Tylenol (acetaminophen) is the first line option for managing pain and fever during pregnancy but recent concerns about the risk of autism for the baby have called Tylenol’s safety into question. We propose that epidemiological linkages between Tylenol use and autism arise from the association between illness during pregnancy and autism risk, rather than Tylenol use itself. Methods: Here we directly test the effects of Tylenol on autism related behaviours that are produced by maternal immune activation (MIA) using poly[I:C] in pregnant mice. These include impaired placental function and fetal well-being, reduced ultrasonic vocalizations in mouse pups, reduced sociability in the three-chamber assay and increased marble burying behaviour in juvenile mice. Conclusions: If treatment with Tylenol reduces the effects of MIA while Tylenol alone shows no effect, this study would provide direct evidence that Tylenol is a safe and effective way to manage illness-related symptoms during pregnancy. ITEMSStage 1 Registered Report Protocol

Authors

Publication Details

Journal
Figshare
Published
2026-11-18
DOI
https://doi.org/10.6084/m9.figshare.34930344
Primary Topic
Autism Spectrum Disorder Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

The effect of Tylenol on autism risk due to maternal illness during pregnancy [Registered Report Stage 1 Protocol]

Ashlyn Swift‐Gallant, S. Hu, Lucas F. Fowler, Lindsay Cahill et al.
4 links
Figshare
Autism Spectrum Disorder Research
article

The effect of Tylenol on autism risk due to maternal illness during pregnancy [Registered Report Stage 1 Protocol]

Ashlyn Swift‐Gallant, S. Hu, Lucas F. Fowler, Lindsay Cahill, Haley Adams, Shrabontee Deepanwita, Tevye Stachniak, Tanya Burry, Kerri Sparkes
article en

Abstract

ABSTRACTBackground: Tylenol (acetaminophen) is the first line option for managing pain and fever during pregnancy but recent concerns about the risk of autism for the baby have called Tylenol’s safety into question. We propose that epidemiological linkages between Tylenol use and autism arise from the association between illness during pregnancy and autism risk, rather than Tylenol use itself. Methods: Here we directly test the effects of Tylenol on autism related behaviours that are produced by maternal immune activation (MIA) using poly[I:C] in pregnant mice. These include impaired placental function and fetal well-being, reduced ultrasonic vocalizations in mouse pups, reduced sociability in the three-chamber assay and increased marble burying behaviour in juvenile mice. Conclusions: If treatment with Tylenol reduces the effects of MIA while Tylenol alone shows no effect, this study would provide direct evidence that Tylenol is a safe and effective way to manage illness-related symptoms during pregnancy. ITEMSStage 1 Registered Report Protocol

Figshare
Good health and well-being
Autism Spectrum Disorder Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon